Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Avita Medical announced earnings per share of $-0.26 on revenue of $5.1M. Analysts polled by Investing.com anticipated EPS of $-0.4879 on revenue of $4.62M.
Avita Medical shares are up 41.87% from the beginning of the year, still down 52.38% from its 52 week high of $55.35 set on February 19, 2020. They are outperforming the Nasdaq which is up 8.83% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Roche Holding ADR had missed expectations on February 1 with fourth quarter EPS of $1.21 on revenue of $15.88B, compared to forecast for EPS of $1.28 on revenue of $16.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar